Crucell and Berna Biotech to Create Large Independent Vaccine Company
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 67 (Table of Contents)
Published: 6 Jan-2006
DOI: 10.3833/pdr.v2006.i67.581 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Crucell entered into an acquisition agreement to acquire Berna Biotech, thus expanding its vaccine portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS